08 Oct 2025 Confo Therapeutics awarded VLAIO grant for development of ultra-long-acting antibody-based GPCR therapeutics in endocrine and metabolic conditions Multiple categories
07 Oct 2025 Biovia supports ALCOVE: early lung cancer detection through breath analysis Multiple categories
06 Oct 2025 Onco3R Therapeutics Announces Completion of First Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671 and Oral Presentation at UEGW 2025 Multiple categories
24 Sep 2025 Enhertu plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer Multiple categories
19 Sep 2025 STEP4NAMs — Biovia joins European effort to boost animal replacement methods Multiple categories
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
